Literature DB >> 8938170

Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sjögren's syndrome.

T Dörner1, E Feist, C Held, K Conrad, G R Burmester, F Hiepe.   

Abstract

Antibodies against the 52-kd Ro(SS-A) protein are significantly associated with the primary Sjogren's syndrome (pSS). A small proportion of patients suffering from primary biliary cirrhosis (PBC) with secondary Sjogren's syndrome (PBC/SS) who are serologically characterized by antimitochondrial type 2 antibodies also express anti-52-kd Ro(SS-A) antibodies. The primary B-cell-derived antigenic responses by autoimmune sera were analyzed in both entities using truncated recombinant proteins to examine whether different epitopes are associated with these diseases. Sera were collected from 25 patients with pSS and 9 anti-52-kd Ro(SS-A)-positive patients suffering from PBC/SS. B-cell epitope mapping was performed using different 52-kd Ro(SS-A) fusion proteins in enzyme-linked immunosorbent assay (ELISA) and immunoblotting. Sera from patients with pSS showed the broadest reactivity against antigenic epitopes at AA 153-245 compared to the significantly limited reactivity against AA 228-245 of sera from patients with PBC. B-cell epitopes within AA 190-245 represent immunodominant epitopes recognized by pSS sera in a significantly higher degree than by PBC sera, which react predominantly with AA 228-245 (P < .0001). Anti-La(SS-B) antibodies were significantly associated with anti-52-kd Ro(SS-A) in sera from patients with pSS compared with PBC patients (P < .025). Thus, the antibody response to 52-kd Ro(SS-A) in PBC appears to be induced differently than in pSS. Although a limited immune response to 52-kd Ro(SS-A) occurs in PBC/SS patients, a more extended epitope spreading is evident in patients with pSS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938170     DOI: 10.1002/hep.510240616

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Autoantigen-targeting microRNAs in Sjögren's syndrome.

Authors:  Ying Yang; Linyi Peng; Weizhi Ma; Fan Yi; Zhenxi Zhang; Hua Chen; Yongqing Guo; Li Wang; Li Dan Zhao; Wenjie Zheng; Jinghui Li; Fengchun Zhang; Quan Du
Journal:  Clin Rheumatol       Date:  2016-02-18       Impact factor: 2.980

2.  Interstitial lung disease and Sjögren's syndrome in primary biliary cirrhosis: a causal or casual association?

Authors:  Bin Liu; Feng Chun Zhang; Zhou Li Zhang; Wen Zhang; Li Xia Gao
Journal:  Clin Rheumatol       Date:  2008-05-30       Impact factor: 2.980

Review 3.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 4.  A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.

Authors:  Adrian Y S Lee
Journal:  Rheumatol Int       Date:  2017-04-17       Impact factor: 2.631

Review 5.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

6.  Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.

Authors:  Athanasios Gkoutzourelas; Christos Liaskos; Maria G Mytilinaiou; Theodora Simopoulou; Christina Katsiari; Alexandra Tsirogianni; Dimitrios Daoussis; Thomas Scheper; Wolfgang Meyer; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.